# RareCan v1.0 Clinical-Grade ctDNA Pipeline

A comprehensive Nextflow-based pipeline for clinical-grade circulating tumor DNA (ctDNA) analysis with UMI-based error correction, designed for AWS HealthOmics deployment.

## ğŸ¯ Project Status

**Current Status:** ~75% Complete - Core Pipeline Functional, Fragmentomics Implemented

**See:** [Project Analysis](docs/PROJECT_ANALYSIS.md) for detailed status

## ğŸ“‹ Features

### âœ… Implemented
- Quality Control (FastP, FastQC, MultiQC)
- Alignment (Minimap2 with BWA fallback)
- Variant Calling (Mutect2, VarDict, LoFreq)
- CNV Analysis (CNVkit)
- Structural Variant Detection (Manta)
- MSI Analysis (MSIsensor2)
- TMB Calculation
- Variant Annotation (VEP)
- Clinical Reporting (JSON/HTML)
- **Fragmentomics Analysis** (Global + Variant signatures)
- **TFX Clinical Report Generation**
- **FHIR-Compliant Reporting**

### âš ï¸ In Progress / Missing
- Complete UMI Consensus Pipeline (partial implementation)
- ichorCNA Integration (tumor fraction estimation)
- CHIP Filtering (module exists, needs integration)
- Validation Framework

## ğŸ“ Project Structure

```
Rarecan_final/
â”œâ”€â”€ main.nf                 # Main Nextflow workflow
â”œâ”€â”€ nextflow.config         # Pipeline configuration
â”œâ”€â”€ modules/                # Nextflow modules
â”‚   â”œâ”€â”€ qc.nf              # Quality control
â”‚   â”œâ”€â”€ umi.nf              # UMI processing
â”‚   â”œâ”€â”€ align.nf            # Alignment (BWA)
â”‚   â”œâ”€â”€ align_minimap2.nf   # Alignment (Minimap2)
â”‚   â”œâ”€â”€ snv.nf              # SNV/INDEL calling
â”‚   â”œâ”€â”€ cnv.nf              # Copy number analysis
â”‚   â”œâ”€â”€ sv.nf               # Structural variants
â”‚   â”œâ”€â”€ msi.nf              # MSI analysis
â”‚   â”œâ”€â”€ tmb.nf              # TMB calculation
â”‚   â”œâ”€â”€ annotate.nf         # Variant annotation
â”‚   â”œâ”€â”€ fragmentomics.nf   # Fragmentomics analysis
â”‚   â”œâ”€â”€ tfx_report.nf       # TFX clinical reports
â”‚   â”œâ”€â”€ fhir_report.nf      # FHIR reporting
â”‚   â””â”€â”€ report.nf           # Clinical reporting
â”œâ”€â”€ bin/                    # Analysis scripts
â”‚   â”œâ”€â”€ global_fragmentomics.py      # Fragment length/motif analysis
â”‚   â”œâ”€â”€ run_variant_fragmentomics.py # Variant-level fragmentomics
â”‚   â”œâ”€â”€ run_final_report.py          # TFX report generator
â”‚   â”œâ”€â”€ run_ichorcna.R               # ichorCNA script
â”‚   â””â”€â”€ [other analysis scripts]
â”œâ”€â”€ assets/                 # Reference files, databases
â”œâ”€â”€ config/                 # Configuration files
â”œâ”€â”€ docs/                   # Documentation
â”‚   â”œâ”€â”€ PROJECT_ANALYSIS.md
â”‚   â””â”€â”€ IMPROVEMENTS_NEEDED.md
â””â”€â”€ validation/             # Validation datasets and workflows
```

## ğŸš€ Quick Start

### Prerequisites
- Nextflow >= 22.10.0
- AWS HealthOmics access (for cloud execution)
- Docker or Singularity (for container execution)

### Basic Usage

```bash
nextflow run main.nf \
    --read1 sample_R1.fastq.gz \
    --read2 sample_R2.fastq.gz \
    --sample_id SAMPLE001 \
    --ref s3://references/hg38.fasta \
    --bed targets.bed \
    --pon_vcf pon.vcf.gz \
    --cnv_pon reference.cnn \
    --outdir /output
```

### Parameters

**Required:**
- `--read1`, `--read2`: Input FASTQ files
- `--sample_id`: Sample identifier
- `--ref`: Reference genome FASTA
- `--bed`: Target regions BED file
- `--pon_vcf`: Panel of Normals VCF
- `--cnv_pon`: CNV reference CNN file

**Optional:**
- `--enable_lofreq`: Enable LoFreq caller (default: false)
- `--enable_duplex`: Enable duplex UMI consensus (default: true)
- `--enable_fragmentomics`: Enable fragmentomics analysis (default: false)
- `--enable_umi`: Enable UMI processing (default: true)
- `--enable_cnv`: Enable CNV analysis (default: true)
- `--enable_sv`: Enable structural variant detection (default: true)
- `--msi_bed`: MSI loci BED file
- `--vep_cache`: VEP cache directory
- `--frag_min_bp`: Minimum fragment length for short fragments (default: 90)
- `--frag_max_bp`: Maximum fragment length for short fragments (default: 150)

## ğŸ”§ Configuration

### AWS HealthOmics

The pipeline is configured for AWS HealthOmics deployment. Update `nextflow.config` with your:
- ECR registry: `965747689553.dkr.ecr.eu-west-2.amazonaws.com/ctdna-universal:latest`
- AWS Batch queue
- S3 bucket paths

### Container

Currently uses a single universal container. See [IMPROVEMENTS_NEEDED.md](docs/IMPROVEMENTS_NEEDED.md) for planned one-process-one-container strategy.

## ğŸ“Š Output Structure

```
output/
â”œâ”€â”€ qc/                    # Quality control reports
â”œâ”€â”€ umi/                   # UMI processing outputs
â”œâ”€â”€ alignment/             # Alignment BAMs and metrics
â”œâ”€â”€ fragmentomics/         # Fragmentomics analysis
â”‚   â”œâ”€â”€ *.fragmentomics.summary.json  # Summary metrics
â”‚   â”œâ”€â”€ *.global_hist.tsv            # Fragment length histogram
â”‚   â””â”€â”€ *.fragment_motifs.tsv        # End motif frequencies
â”œâ”€â”€ variants/
â”‚   â”œâ”€â”€ snv/              # SNV/INDEL VCFs
â”‚   â”œâ”€â”€ cnv/              # CNV calls
â”‚   â””â”€â”€ sv/               # Structural variants
â”œâ”€â”€ msi/                  # MSI analysis results
â”œâ”€â”€ tmb/                  # TMB calculations
â”œâ”€â”€ annotation/            # Annotated variants
â””â”€â”€ reports/              # Clinical reports (JSON/HTML)
```

## âš ï¸ Known Issues & Limitations

1. **UMI Processing**: Module exists but not fully integrated into main workflow
2. **ichorCNA**: Module exists but requires proper container configuration
3. **CHIP Filtering**: Module exists, needs full integration
4. **Reference Genome**: Currently using placeholder reference - requires full hg38 for production
5. **Licensing**: Manta, MSIsensor2 require commercial licenses for production use

See [IMPROVEMENTS_NEEDED.md](docs/IMPROVEMENTS_NEEDED.md) for detailed list.

## ğŸ“š Documentation

- [Project Analysis](docs/PROJECT_ANALYSIS.md) - Comprehensive status and gap analysis
- [Improvements Needed](docs/IMPROVEMENTS_NEEDED.md) - Critical fixes and enhancements

## ğŸ”¬ Clinical Validation

**Status:** Validation framework not yet implemented

**Planned:**
- Tier 1: Analytical validation (SafeMut, HG002)
- Tier 2: Scientific validation (MSK-IMPACT concordance)
- Tier 3: Clinical validation (EGA-4847 dataset)

## ğŸ“ License & Compliance

**Current Status:** âš ï¸ License compliance issues exist

- Manta: Polyform Strict License (requires Illumina negotiation)
- MSIsensor2: GPL-3.0 (should use MSIsensor-pro for commercial)
- ichorCNA: GPL-3.0 (requires isolation)

**Action Required:** Resolve licensing before commercial deployment

## ğŸ¤ Contributing

This is a clinical-grade pipeline under active development. See project documentation for contribution guidelines.

## ğŸ“§ Contact

For questions or issues, refer to project documentation or contact the development team.

## ğŸ”„ Version History

- **v1.0.0** (Current): Foundation implementation with core modules
  - Basic variant calling pipeline
  - Partial UMI implementation
  - Clinical reporting framework

---

**Note:** This pipeline is designed for clinical use and requires proper validation and regulatory compliance before deployment in clinical settings.

